Company / Financials
Harmony Biosciences Holdings, Inc. Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$868.5M
FY2025 · +21.5% YoY
Net Income
$158.7M
FY2025 · +9.1% YoY
Profit Margin
18.3%
FY2025 · net income / revenue
ROE
18.2%
FY2025 · return on equity
Total Assets
$1.3B
FY2025
Total Debt
$163.7M
0.19x debt/equity
Equity
$870.2M
FY2025
ROA
12.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$868.5M+21.5% YoYNet Income HistoryProfit after all expenses and taxes$158.7M+9.1% YoYGross Profit HistoryRevenue minus cost of goods sold$670.1M+20.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$198.3M+26.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes$208.5M+9.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$152.5M+38.2% YoYR&D Expense HistoryResearch and development spending$189.6M+30.0% YoYInterest Expense HistoryCost of borrowing and debt obligations$14.6M-16.3% YoYIncome Tax HistoryTotal income tax expense$56.4M+21.7% YoYEPS (Basic) HistoryBasic earnings per share$2.17-29.3% YoY